Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation

Cited by (317)

Items 301–317 of 317

1. Quantifying the Acute Toxicity of Alpha-Synuclein Membrane-Accumulation in a Cell-Based Assay
   Baoyi Li, Amirah K. Anderson, Heba Alnakhala, Oren A. Levy, Nagendran Ramalingam, Ulf Dettmer · 2026 · Journal of Molecular Neuroscience
2. Investigating the efficacy, methods, and challenges of induced pluripotent stem cells (iPSC) therapy in Parkinson's disease
   Mohammed Ahmed Mustafa, Shaker Al-Hasnaawei, Irwanjot Kaur, H Malathi, Laxmidhar Maharana, Archana Dhyani, Ashish Singh Chauhan, Jatin Sharma, Deepak Nathiya · 2026 · Neurological Sciences
3. Incense Aerosol-Induced Neurotoxicity Disrupts α-Synuclein Homeostasis in a Cellular Parkinson’s Disease Model, Distinct from Cigarette Aerosols
   Y. K. Tseng, Ming-Chu Teng, Yu-Siou K Huang, Chia-Hsuan Pan, Yuan-Pin Chang, Chia C. Wang, Hsiu‐Fang Fan · 2026 · Chemical Research in Toxicology
4. Détection et caractérisation de l'α-synucléine dans le système nerveux entérique en conditions physiologiques et dans la maladie de Parkinson
   Anne-Gaëlle Corbillé · 2016 · theses.fr (ABES)
5. Étude moléculaire de la propagation de l’agrégation de l’alpha-synucléine dans un modèle transgénique de la maladie de Parkinson : impact de la surexpression de la beta-synucléine à l’aide de vecteurs viraux adéno-associés (AAV)
   Dorian Sargent · 2018 · theses.fr (ABES)
6. Development of Inhibitors of Amyloid Fibril Propagation
   Maya Bendifallah · 2019 · theses.fr (ABES)
7. Étude de la propagation prion-like de l'alpha-synucléine dans des réseaux de neurones reconstruits
   Josquin Courte · 2019 · theses.fr (ABES)
8. Etude de la coopération de l'alpha-synucléine et de LRRK2 dans les dysfonctions mitochondriales dans la Maladie de Parkinson
   Camille Gardier · 2019 · theses.fr (ABES)
9. Inducing β-hairpin and α-helix folding in peptides : design, synthesis and evaluation of α-synuclein and tau aggregation inhibitors
   Nicolò Bisi · 2023 · theses.fr (ABES)
10. Conception, Synthèse et Analyse Structurale de Foldamères Fluorés de Conformation Hélicoïdale Polyproline de type II Ciblant des Membranes ou des Protéines Amyloïdes
    Chloé Cayrou · 2024
11. The Emerging Parkinson's Disease Oxylipin‐Ome
    Julia C. Kelliher, Saranna Fanning · 2026 · Advanced Science
12. Combined Effects of Mutation and Ionic Strength on α-Synuclein Reveal Generic Features of Aggregation-Prone Monomeric States
    Vaishnavi Tammara, Ankita Das, Zion Desai, Atanu Das · 2026 · ACS Chemical Neuroscience
13. Plasma cfDNA hypermethylation at SNCA intron 1 as a potential blood-based epigenetic signal in Parkinson's disease and multiple system atrophy
    Songnian Hu, Chao Ying, Jinhua Xue, Lifang Zhao, Hong Sun, Yanning Cai · 2026 · Parkinsonism & Related Disorders
14. Crosstalk Between Parkinson's Disease and Colorectal Cancer: Genetic Mechanisms, Gut Microbiota, and Therapeutic Insights
    Jiacheng Ying, Zhengyuan Fang, C L Zhang, Xu Liu, Jianzhi Cui, Zezhi Li, Jia‐Yin Tang · 2026 · Health care science
15. Mitochondrial resilience: a convergent framework for pathogenesis and neuroprotection in Parkinson’s disease
    Óscar Arias-Carrión, Magdalena Guerra‐Crespo, Luis Oskar Soto-Rojas, Yeminia Valle, Emmanuel Ortega‐Robles, Daniel Ortuño‐Sahagún · 2026 · Frontiers in Pharmacology
16. Retromer-targeted therapy for neurodegenerative diseases
    Michele Persico, Sophronea Tuithung, Alejandra Lorenzo, Darynaisha Crawford, Simona Eleuteri, David K. Simon · 2026 · Molecular Neurodegeneration
17. From dosage alteration to amplification strategies: mechanistically defined alpha-synuclein mouse models for Parkinson’s disease therapy development
    Silke Nuber, Saranna Fanning, Ulf Dettmer · 2026 · Acta Neuropathologica